BioSpace News Archive

Biotech Bay

S2 Genomics Raises Series A Round Led by BroadOak Capital Partners and RCT

S2 Genomics announced today that it has raised $16 million in Series A funding from BroadOak Capital Partners and Research Corporation Technologies (RCT).

January 23, 2024
·
2 min read
Drug Development

IAMA Therapeutics Announces First Subject Dosed in Phase 1 Study of IAMA-6 for the Treatment of Autism and Epilepsy

IAMA Therapeutics Announces First Subject Dosed in Phase 1 Study of IAMA-6 for the Treatment of Autism and Epilepsy.

January 23, 2024
·
2 min read
Drug Development

Cybin Announces FDA Clearance to Initiate a Phase 2a Study of CYB004 in Generalized Anxiety Disorder

Cybin Inc. today announced that the U.S. Food and Drug Administration (“FDA”) has cleared its investigational new drug (“IND”) application for CYB004, its proprietary deuterated dimethyltryptamine (“DMT”) molecule in development for the treatment of Generalized Anxiety Disorder (“GAD”).

January 23, 2024
·
8 min read
BioMidwest

IAOMT Position Paper Examines the Science of Jawbone Cavitations Just Ahead of the Yankee Dental Congress!

The International Academy of Oral Medicine and Toxicology is pleased to announce the publication of its new position paper on Human Jawbone Cavitations.

January 23, 2024
·
2 min read
Biotech Bay

Anixa Biosciences Announces Japanese Patent on Ovarian Cancer Vaccine Technology

Anixa Biosciences, Inc. today announced that its collaborator, Cleveland Clinic, has received a “Decision to Grant” notice from the Japan Patent Office (JPO) for the patent application titled “Ovarian Cancer Vaccines.”

January 23, 2024
·
5 min read
Business

Biognosys Expands US Footprint with New Proteomics CRO Facility in Massachusetts

Biognosys, a leader in next-generation proteomics solutions for drug discovery and development, announced the operational readiness of its new proteomics facility in Massachusetts.

January 23, 2024
·
5 min read
Medivir invites to a conference call today on updated data at ASCO GI and the plans moving forward for fostrox in primary liver cancer (HCC)

Medivir AB, a pharmaceutical company focused on developing innovative treatments for cancer in areas of high unmet medical need, invites to a conference call on the updated data from the ongoing phase 1b/2a study in advanced hepatocellular carcinoma.

January 23, 2024
·
4 min read
Lone Star Bio

Baird Medical Performs First Thyroid Microwave Ablation Procedure in the United States

Baird Medical Devices, Inc. announced that it has performed its first thyroid MWA procedure in the United States since obtaining registration clearance from the U.S. Food and Drug Administration on November 22, 2023.

January 23, 2024
·
4 min read
Business

Hippofi Welcomes Scott Bauccio as New Head of Sales for Pur Biologics

HippoFi’s biotechnology business PUR Biologics, proudly announces Scott Bauccio as its new Head of Sales.

January 23, 2024
·
3 min read
Business

Synthego and SeQure Dx Partner to Provide Comprehensive Off-Target Analysis Services for CRISPR-Based Therapeutics Developers

Synthego and SeQure Dx have announced a strategic partnership to provide CRISPR-based therapeutics developers with comprehensive off-target editing analytical services that include best-in-class technology and turn-key end-to-end development solutions.

January 23, 2024
·
4 min read